Screener
Fulgent Genetics, Inc. FLGT Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Fulgent Genetics, Inc.’s reported figures.
The source filing: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 7:08 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-199065
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $71,138 | $73,463 |
| Cost of revenue | 49,648 | 45,117 |
| Gross profit | 21,490 | 28,346 |
| Operating expenses | ||
| Research and development | 14,176 | 12,395 |
| Selling and marketing | 12,221 | 8,465 |
| General and administrative | 27,684 | 25,291 |
| Amortization of intangible assets | 2,031 | 1,990 |
Item 1. Financial Statements.
FAQ
- What is Fulgent Genetics, Inc.'s gross profit?
- Fulgent Genetics, Inc. (FLGT) reported gross profit of $21.49M in Q1 2026.
- How has Fulgent Genetics, Inc.'s gross profit changed year-over-year?
- Fulgent Genetics, Inc.'s gross profit decreased by 24.2% year-over-year, from $28.35M to $21.49M.
- What is the long-term trend for Fulgent Genetics, Inc.'s gross profit?
- Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s gross profit has grown at a -35.9% compound annual growth rate (CAGR), from $777.05M to $130.88M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Fulgent Genetics, Inc.'s gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude